This inventor holds 2 USPTO granted patents. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1996
Title: Mikako Tsuchiya: Innovator in Protein Detection Technologies
Introduction
Mikako Tsuchiya is a notable inventor based in Izumo, Japan. She has made significant contributions to the field of protein detection, particularly through her work on guanine nucleotide binding proteins. With a total of 2 patents, her innovations have the potential to advance medical diagnostics and research.
Latest Patents
Mikako Tsuchiya's latest patents focus on the detection of ARD 1 protein in samples. The first patent describes a method that involves providing labeled or immobilized anti-ARD 1 antibody in a reaction zone. The process includes introducing a sample into the reaction zone, allowing the ARD 1 protein, if present, to react with the antibody and form an immunological complex. The formation of this complex can then be detected. Additionally, the patent outlines cells, nucleotide and amino acid sequences, and vectors associated with ARD 1. The second patent mirrors the first, emphasizing the same innovative method for detecting ARD 1 protein.
Career Highlights
Mikako Tsuchiya works for the United States of America as represented by the Department of Health. Her role involves significant research and development in the field of protein detection, contributing to advancements in health and medical diagnostics.
Collaborations
Mikako has collaborated with notable colleagues, including Joel Moss and Maria S Nightingale. Their combined expertise enhances the research and development efforts in their respective fields.
Conclusion
Mikako Tsuchiya's work in protein detection technologies exemplifies innovation in the scientific community. Her patents not only contribute to the understanding of ARD 1 protein but also pave the way for future advancements in medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
